Previous 10 | Next 10 |
WARMINSTER, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (includin...
Source: Explained: The challenges in developing a COVID-19 vaccine The COVID pandemic has destroyed global economies and this had led to an open checkbook in the search for a vaccine. However, in science facts matter and the size of the spend doesn’t guarantee success. Things ar...
MediciNova (NASDAQ: MNOV ) -21% . More news on: MediciNova, Inc., Wilhelmina International, Inc., Allena Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Investment Thesis The much-awaited peer-reviewed data of mRNA-1273, the COVID-19 vaccine candidate of Moderna, Inc. ( MRNA ), has left many questions unanswered. Though the vaccine has been safe and produced neutralizing antibodies, the Phase 3 trial will look for the vaccine's clinical ef...
Moderna has mixed luck with patent snub, but moves ahead with COVID-19 vaccine Moderna (MRNA) suffered a setback as the company lost its patent case against Arbutus Biopharma (ABUS). The company had appealed for the revocation of Arbutus's '069 patent on the ground of describing "obvious...
Arbutus Biopharma (NASDAQ: ABUS) has for some years owned the rights to a technology that can be used to deliver messenger RNA to a patient's cells. Back in January 2019, Moderna (NASDAQ: MRNA) , whose entire drug platform is based upon messenger RNA, filed a petition with the U.S. P...
Could These Biotech Stocks Continue Their Rally Next Week? Biotech stocks have outperformed the broader market year to date. Coronavirus isn’t the only reason for this either. The market for other immunotherapies is also showing positive signs. After all, coronavirus isn’t the ...
Natuzzi (NYSE: NTZ ) +131% on renewing its securitization facility. More news on: Natuzzi S.p.A., Miragen Therapeutics, Theratechnologies Inc., Stocks on the move, Read more ...
Mexco Energy (NYSEMKT: MXC ) +153% . More news on: Mexco Energy Corporation, Oblong Inc., Oragenics, Inc., Stocks on the move, , Read more ...
Last year I created a public screen on Portfolio123, a web-based subscription service that allows you to backtest screens and ranking systems. It invests in companies in the Russell 3000 that spend heavily on R&D. There were four rules in the screen, but the most important were these: ...
News, Short Squeeze, Breakout and More Instantly...
Arbutus Biopharma Corporation Company Name:
ABUS Stock Symbol:
NASDAQ Market:
Arbutus Biopharma Corporation Website:
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it ...
Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmac...
In t he HBV003 trial, 67% of participants had HBsAg <10 IU/mL and 19% of participants had undetectable HBsAg when assessed for NUC discontinuation (end of treatment) or later, and 76% of participants were eligible for nucleos(t)ide analogue (NUC) therapy discontinuation. In the...